Department of Internal Medicine, Department of Biochemistry, Justus Liebig University, Universities of Giessen and Marburg Lung Center, German Center for Lung Research, 35392 Giessen, Germany.
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):E374-83. doi: 10.1073/pnas.1306798111. Epub 2013 Dec 9.
TGF-β is a pathogenic factor in patients with acute respiratory distress syndrome (ARDS), a condition characterized by alveolar edema. A unique TGF-β pathway is described, which rapidly promoted internalization of the αβγ epithelial sodium channel (ENaC) complex from the alveolar epithelial cell surface, leading to persistence of pulmonary edema. TGF-β applied to the alveolar airspaces of live rabbits or isolated rabbit lungs blocked sodium transport and caused fluid retention, which--together with patch-clamp and flow cytometry studies--identified ENaC as the target of TGF-β. TGF-β rapidly and sequentially activated phospholipase D1, phosphatidylinositol-4-phosphate 5-kinase 1α, and NADPH oxidase 4 (NOX4) to produce reactive oxygen species, driving internalization of βENaC, the subunit responsible for cell-surface stability of the αβγENaC complex. ENaC internalization was dependent on oxidation of βENaC Cys(43). Treatment of alveolar epithelial cells with bronchoalveolar lavage fluids from ARDS patients drove βENaC internalization, which was inhibited by a TGF-β neutralizing antibody and a Tgfbr1 inhibitor. Pharmacological inhibition of TGF-β signaling in vivo in mice, and genetic ablation of the nox4 gene in mice, protected against perturbed lung fluid balance in a bleomycin model of lung injury, highlighting a role for both proximal and distal components of this unique ENaC regulatory pathway in lung fluid balance. These data describe a unique TGF-β-dependent mechanism that regulates ion and fluid transport in the lung, which is not only relevant to the pathological mechanisms of ARDS, but might also represent a physiological means of acutely regulating ENaC activity in the lung and other organs.
TGF-β 是急性呼吸窘迫综合征 (ARDS) 患者的致病因素,这种病症的特征是肺泡水肿。文中描述了一种独特的 TGF-β 途径,该途径可迅速促进肺泡上皮细胞表面的 αβγ 上皮钠离子通道 (ENaC) 复合物内化,导致肺水肿持续存在。TGF-β 被应用于活兔的肺泡气腔或分离的兔肺中,可阻断钠转运并导致液体潴留,这与膜片钳和流式细胞术研究一起,确定了 ENaC 是 TGF-β 的靶标。TGF-β 可快速、连续地激活磷酯酶 D1、磷脂酰肌醇-4-磷酸 5-激酶 1α 和烟酰胺腺嘌呤二核苷酸磷酸氧化酶 4 (NOX4),从而产生活性氧,驱动 βENaC 的内化,βENaC 是负责 αβγENaC 复合物细胞表面稳定性的亚基。ENaC 的内化依赖于 βENaC Cys(43)的氧化。用 ARDS 患者的支气管肺泡灌洗液处理肺泡上皮细胞,可驱动 βENaC 内化,而 TGF-β 中和抗体和 Tgfbr1 抑制剂可抑制其内化。体内抑制小鼠的 TGF-β 信号转导,以及在小鼠中遗传敲除 nox4 基因,可防止博莱霉素肺损伤模型中肺液平衡紊乱,突出了这个独特的 ENaC 调节途径的近端和远端成分在肺液平衡中的作用。这些数据描述了一种独特的 TGF-β 依赖性机制,可调节肺中的离子和液体转运,这不仅与 ARDS 的病理机制有关,而且可能代表了一种生理方式,可在肺和其他器官中急性调节 ENaC 活性。